UK-based Laverock Therapeutics Expands Gene-Silencing Technology to Tackle Multiple Disease Areas
Laverock Therapeutics, a UK company based at the Stevenage Bioscience Catalyst, is advancing its programmable gene-silencing platform, GEiGS, aimed at …